Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eslicarbazepine acetate in Post-Herpetic Neuralgia
NCT01124097Phase 3Terminated
- Sponsor
- BIAL
- Start
- Sep 2010
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of eslicarbazepine acetate in postherpetic neuralgia (PHN), sponsored by BIAL. Started Sep 2010; status: terminated.
02
Drugs
eslicarbazepine acetate
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT01124097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01124097.